Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 30, 2026

Study Completion Date

July 30, 2026

Conditions

Cervical Cancer

Trial Locations (1)

Anhui Provincal Hospital, Hefei

All Listed Sponsors

lead

Anhui Provincial Hospital

OTHER_GOV